Glenmark Pharmaceuticals Inc., USA recalls Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenma
Recalled July 24, 2024 · FDA recall D-0605-2024 · Glenmark Pharmaceuticals Inc., USA
Hazard
Failed Dissolution Specifications · FDA Class I
Units
36,630 bottles
Sold at
Nationwide
Description
Failed Dissolution Specifications
Product
Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-05
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →